Variant report
Variant | esv2483378 |
---|---|
Chromosome Location | chr7:84108338-84109715 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs183547465 | chr7:84108398-84108399 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs536879220 | chr7:84108410-84108411 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs548780680 | chr7:84108481-84108482 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs142594174 | chr7:84108568-84108569 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs534605035 | chr7:84108575-84108576 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs552805987 | chr7:84108625-84108626 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs571215946 | chr7:84108645-84108646 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs2715034 | chr7:84108661-84108662 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs539017974 | chr7:84108664-84108665 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs557210769 | chr7:84108673-84108674 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs540707882 | chr7:84108721-84108722 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs575711471 | chr7:84108734-84108735 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs543117445 | chr7:84108773-84108774 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs561471481 | chr7:84108781-84108782 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs117975677 | chr7:84108782-84108783 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs540969534 | chr7:84108784-84108785 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs565569623 | chr7:84108789-84108790 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs532817711 | chr7:84108790-84108791 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs551340045 | chr7:84108800-84108801 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs563102743 | chr7:84108804-84108805 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs17159078 | chr7:84108818-84108819 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs536987548 | chr7:84108833-84108834 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs187424362 | chr7:84108848-84108849 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs534498084 | chr7:84108856-84108857 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs376053480 | chr7:84108932-84108933 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs190043153 | chr7:84108958-84108959 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs571494705 | chr7:84108997-84108998 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs563475445 | chr7:84109209-84109210 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs142844742 | chr7:84109210-84109211 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs567078736 | chr7:84109267-84109268 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs17159079 | chr7:84109268-84109269 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs535700480 | chr7:84109277-84109278 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs138998935 | chr7:84109312-84109313 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs568078095 | chr7:84109317-84109318 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs575665551 | chr7:84109330-84109331 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs536755037 | chr7:84109346-84109347 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs555091659 | chr7:84109348-84109349 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs573524074 | chr7:84109379-84109380 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs182631818 | chr7:84109447-84109448 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs186636734 | chr7:84109512-84109513 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs577480589 | chr7:84109518-84109519 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs544549527 | chr7:84109539-84109540 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs563298253 | chr7:84109559-84109560 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs530383508 | chr7:84109560-84109561 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs141426774 | chr7:84109563-84109564 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs560644737 | chr7:84109592-84109593 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs527566804 | chr7:84109608-84109609 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs150410516 | chr7:84109652-84109653 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs17159080 | chr7:84109676-84109677 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs138204065 | chr7:84109684-84109685 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17170743 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Biliary cancer | 19435499 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Cancer | 21183584 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Gastric cancer | 24379144 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lissencephaly | 21572526 | CNVD |
Breast cancer | 17603634 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Williams-beuren syndrome | 16826523 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Wilms tumour | 19318497 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Schizophrenia | 17879154 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 16461572 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 20858243 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21611746 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:84107000-84109600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr7:84107000-84109600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
3 | chr7:84107200-84109800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
4 | chr7:84107600-84108600 | Weak transcription | H1 Cell Line | embryonic stem cell |
5 | chr7:84107600-84108600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
6 | chr7:84107600-84108600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
7 | chr7:84107600-84114800 | Weak transcription | NHDF-Ad | bronchial |
8 | chr7:84107600-84116600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
9 | chr7:84108000-84108400 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
10 | chr7:84108000-84108400 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
11 | chr7:84108200-84109600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
12 | chr7:84108400-84109400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
13 | chr7:84108400-84109800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
14 | chr7:84108600-84108800 | Enhancers | H1 Cell Line | embryonic stem cell |
15 | chr7:84108600-84108800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
16 | chr7:84108600-84109600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
17 | chr7:84109200-84120000 | Weak transcription | Fetal Muscle Trunk | muscle |